IL10 and angioimmunoblastic T-cell lymphoma: If blockade of IL-10–mediated M2 macrophage polarization could be combined with CHOP chemotherapy or immune checkpoint inhibitors such as pembrolizumab, the treatment outcome of AITL might be improved.